O'Malley Lab
Mastering The Master Regulators of Gene Function
Starting in the 1970s and continuing to today, the O’Malley lab has been a pioneer in the research, development, and therapeutic potential of steroid receptor coactivators (SRCs)–which turned out to be the long sought-after ‘master regulators’ of genetic function. Their discoveries have transformed the field and are poised to reshape the treatment of serious diseases. CoRegen was founded on the legacy of these groundbreaking scientific advancements.
45 years of research
400 papers on gene regulation
300 papers on coactivators
.jpg)
Gorlin Companies
A Visionary in Biotech Commercialization
Steve Gorlin, CoRegen’s Executive Chairman and Founder, has spent the last four decades identifying and commercializing drugs, therapies, and medical devices from leading research institutions. Recognized as one of the most prolific biotech entrepreneurs in the country, he has founded six companies that reached valuations over $1 billion, including one surpassing $14 billion. His expertise in product commercialization and strategic growth strengthens CoRegen’s ability to bring groundbreaking therapies to market.
“The promise of this therapeutic approach and the science behind it is unlike anything I’ve seen before. This is a game changer, a groundbreaking approach that will benefit millions.”
~ Steve Gorlin, CoRegen Founder & Executive Chairman
Our Mission
Advancing life-changing therapies with innovation and purpose.
Our mission is to pioneer next-generation treatments that eliminate a wide range of chronic illnesses and redefine what’s possible in modern medicine. Through relentless research, cutting-edge biotechnology, and an unwavering commitment to patients, we are reshaping the future of healthcare. CoRegen is founded on these key principles.
Scientific Excellence
We push the boundaries of discovery, grounding every advancement in rigorous, evidence-based research and testing.
Collaboration
We believe true progress comes from collaboration. By uniting the leading minds in biotech and pharma, we drive innovation forward.
Patient Driven
Every breakthrough is fueled by our passion to improve and save lives, with patient outcomes at the heart of our work.
Global Transformation
Our commitment goes beyond innovation, we are dedicated to making our therapies accessible and changing lives around the world.